Assessment of tolerability by the investigator (the investigator will assess tolerability at the end of treatment A and B according to the categories "good", "satisfactory", "not satisfactory", and "bad") [ Time Frame: 7.5 weeks ] [ Designated as safety issue: No ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01374802